4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

Subjects

Subjects :

Microbiology
QR1-502
Public aspects of medicine
RA1-1270

Details

Language :

English

ISSN :

20556640

Volume :

3

Issue :

7-

Database :

Directory of Open Access Journals

Journal :

Journal of Virus Eradication

Publication Type :

Academic Journal

Accession number :

edsdoj.0b3981f1e02d4c4e81030e6bef9aa779

Document Type :

article

Full Text :

https://doi.org/10.1016/S2055-6640(20)30709-3